Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-004888
Filing Date
2025-02-20
Accepted
2025-02-20 16:51:10
Documents
1
Period of Report
2025-02-18

Document Format Files

Seq Description Document Type Size
1 form4-02202025_090206.html 4  
1 form4-02202025_090206.xml 4 3911
  Complete submission text file 0001415889-25-004888.txt   5390
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Issuer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ANNEXON, INC. 180 KIMBALL WAY, SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Yednock Ted (Reporting) CIK: 0001818525 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39402 | Film No.: 25646263